JP Morgan Chase
AH

JP Morgan Chase’s Accretive Health AH Stock Holding History

JP Morgan Chase’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-19,206
Closed -$176K – 4442
2013
Q3 		$176K Sell
19,206
-5,305
-22% -$52.7K ﹤0.01% 4086
2013
Q2 		$265K Buy
+24,511
New +$258K ﹤0.01% 3880

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CII
CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

JP Morgan Chase's AH Position: Q4 2013 in Review

JP Morgan Chase sold out of Accretive Health (AH) in Q4 2013, closing a stake of 19,206 shares — an estimated $176K sold.

JP Morgan Chase first reported a position in AH in Q2 2013 and held it in 2 quarters. The position peaked at $265K in Q2 2013. 85 funds tracked by Wall St. Rank hold AH as of Q4 2013.

  • JP Morgan Chase reported no remaining Accretive Health position as of Q4 2013 after selling out during the quarter.
  • JP Morgan Chase sold 19,206 Accretive Health shares in Q4 2013, an estimated $176K.
  • JP Morgan Chase first reported a position in Accretive Health in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's Accretive Health position peaked at $265K in Q2 2013.
  • 85 funds tracked by Wall St. Rank held Accretive Health as of Q4 2013.

Based on JP Morgan Chase's 13F filing for Q4 2013, filed 13 Feb 2014.